FDA OKs New Kids ' Dose of Cancer Drug
WASHINGTON -- The FDA has approved a pediatric dosage of the cancer drug everolimus (Afinitor Disperz) for the treatment of a rare brain tumor.
Source: MedPage Today Product Alert - Category: Drugs & Pharmacology Source Type: alerts
More News: Brain | Brain Cancers | Brain Tumor | Cancer | Cancer & Oncology | Children | Drugs & Pharmacology | Neurology | Pediatrics